United for Medical Research publishes tribute to Francis Collins

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

United for Medical Research released a video tribute honoring NIH Director Francis Collins, who plans to step down this year. 

Collins will continue his research at the National Human Genome Research Institute after this transition. Lawrence Tabak will serve as NIH interim director. 

Members of the biomedical research community described Collins as a “trusted voice” who has been able to “make NIH a bipartisan priority” with “great charm and elegance,” UMR officials said.

Collins, a physician-geneticist, is the longest-serving presidentially appointed NIH director, having served three U.S. presidents over more than 12 years. Under his leadership, the NIH has undertaken health issues including Alzheimer’s disease, cancer, opioid use disorder, rare diseases, and the COVID-19 pandemic—and the NIH budget has grown from $30 billion

in 2009 to $41.3 billion in 2021.

Collins is known for his commitment to developing and retaining young researchers and working to make biomedical research more accessible and equitable, recently encouraging an end to “manels”—all-male speaking panels. 

Leaders from the following organizations participated in the video: Alzheimer’s Association, American Association for the Advancement of Science, Association of American Universities, Association of Public and Land-grant Universities, Corning Life Sciences, Harvard University, Johns Hopkins University, Northwestern University, Stanford University, Thermo Fisher Scientific, Vanderbilt University, Vanderbilt University Medical Center, and Washington University in St. Louis.  

A transcript of their full statements is available here.

YOU MAY BE INTERESTED IN

On Feb. 3, the House of Representatives passed the Senate Amendment to H.R. 7148, the Consolidated Appropriations Act, 2026, by a vote of 217 to 214. Later that day, President Donald Trump signed the bill into law, officially ending the brief partial government shutdown that began on Jan. 31. 
NIH announced Jan. 29 that “Basic Experimental Studies Involving Humans,” also called BESH, will no longer be considered clinical trials and will therefore no longer be subject to the requirements under the NIH definition of a clinical trial, including registration and reporting requirements in ClinicalTrials.gov.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several  aggressive cuts the White House had proposed for NIH.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login